Livongo

Good plan — you’ll want a telehealth provider that (1) prescribes GLP‑1s/semaglutide for your indication (Type 2 diabetes vs. weight loss), (2) coordinates baseline and ongoing labs, and (3) provides ongoing follow‑up and medication adjustments. Below are several reputable options and when each is a good fit. Telehealth primary‑care or chronic‑disease options (best if you want full diabetes management) One Medical — virtual-first primary care with same‑day televisits, in‑person labs/visits where needed, and continuity of care. Good if you want a regular PCP relationship and lab coordination. PlushCare — offers primary care and chronic‑care management (including diabetes) with regular follow ups; often works with insurers and can arrange labs. Teladoc / Livongo — large telehealth + diabetes programs that can manage Type 2 diabetes and coordinate testing/monitoring, good for structured diabetes care. Onduo — diabetes‑focused program (Verily/Sanofi) designed for people with T2D; focuses on virtual diabetes management and care coordination. Telehealth weight‑loss / GLP‑1 focused services (good if your primary goal is weight management) Ro (Roman) — consumer‑friendly weight‑loss program that offers GLP‑1 prescriptions and ongoing follow up; convenient online workflow but typically cash/plan fees. Hims & Hers — weight‑management programs that may prescribe semaglutide for eligible patients; easy enrollment and follow up for weight-focused care. Lemonaid Health — simpler, lower‑cost telemedicine that in many states prescribes semaglutide for weight loss; check availability by state. Other longitudinal virtual PCP options SteadyMD or Carbon Health — pair you with a virtual PCP for ongoing management and labs; better if you want one provider managing all meds. How to choose (quick checklist to ask each service) Do you explicitly prescribe Ozempic (brand) or semaglutide for my condition (T2D vs weight loss)? Will you order baseline labs (A1c, creatinine, LFTs) and ongoing monitoring? How often are follow‑ups, and who adjusts other diabetes meds (insulin, sulfonylureas) to avoid hypoglycemia? Do you accept my insurance and handle prior authorizations, or is it cash priced? Can you transfer/receive my medical records and recent labs from my current doctor? Safety note If you’re on insulin or sulfonylureas, transitioning care requires careful dose adjustments to avoid hypoglycemia. Any telehealth service should review current meds and labs before prescribing. If you tell me whether your main reason is diabetes control or weight loss, your state (some services are state‑restricted), and whether you need in‑network insurance coverage, I can recommend the single best option and draft the exact questions to ask when you sign up.

Mentioned in position 4 of 10

Short answer If you can’t get Ozempic (semaglutide), the closest substitutes are other GLP‑1 receptor agonists (injectable or oral) and, for diabetes, non‑GLP‑1 classes (SGLT2s, DPP‑4s, insulin). For weight loss there are also non‑GLP‑1 medications. Which is best depends on whether you’re treating type 2 diabetes or trying to lose weight, your medical history, and insurance/price. Main medication alternatives (names and why) Tirzepatide (Mounjaro for diabetes; Zepbound for weight): currently the most potent for glucose lowering and weight loss in trials. Often used when semaglutide is unavailable. Semaglutide formulations: Wegovy (higher‑dose semaglutide for weight loss) and Rybelsus (oral semaglutide — tablet form for diabetes) — same drug family, different dosing/formulation. Liraglutide (Victoza for diabetes; Saxenda for weight loss): a long‑standing GLP‑1 option, effective for both glucose and weight control. Dulaglutide (Trulicity): once‑weekly GLP‑1 commonly used for diabetes; less weight loss than tirzepatide/semaglutide but widely available. Exenatide (Byetta/Bydureon): older GLP‑1 options — Byetta is twice‑daily, Bydureon is once‑weekly. If GLP‑1s aren’t appropriate/available for diabetes: SGLT2 inhibitors (Jardiance/empagliflozin, Farxiga/dapagliflozin), DPP‑4 inhibitors (Januvia/sitagliptin), or insulin — these control glucose but have different effects on weight and cardiovascular risk. For weight management only (non‑GLP‑1): Saxenda (liraglutide), Qsymia (phentermine/topiramate), Contrave (bupropion/naltrexone), orlistat (Xenical/Alli); each has different effectiveness and side effects. Who prescribes these online Many reputable telehealth and virtual primary‑care services evaluate patients and can prescribe GLP‑1s, tirzepatide, or alternatives when clinically appropriate. Examples (U.S.-based, reputable): PlushCare — virtual primary care and chronic disease management; prescribers commonly manage diabetes meds and GLP‑1s. Ro (Roman) / Zero — offers weight‑loss telehealth programs that may prescribe GLP‑1s and other weight meds. Hims & Hers Health — provides telehealth weight‑loss programs and prescribes some GLP‑1s and other anti‑obesity medications. Lemonaid Health — telemedicine clinic that prescribes diabetes and weight‑loss meds (including semaglutide in many locations). GoodRx Care — telehealth visits with prescriptions and coupons/discounts; will frequently prescribe alternatives when appropriate. One Medical (primary care with telehealth visits) — continuity care and chronic disease management; can prescribe and coordinate prior authorizations. Specialized diabetes programs (e.g., Onduo, Livongo-style programs through insurers) — for patients with diabetes, these programs sometimes prescribe and manage GLP‑1s and SGLT2s. What to expect from telehealth services You’ll typically need a medical evaluation (medical history, current meds, sometimes recent labs such as A1c, kidney function). Some services require participation in a monitoring program (check-ins, weight tracking). For weight drugs, many programs combine counseling and monitoring. Prior authorization and insurance coverage vary — companies sometimes help with prior auth or manufacturer savings programs. Not every telemedicine service can/will prescribe every drug (some avoid off‑label uses, or certain companies limit newer drugs like tirzepatide). Safety and practical notes GLP‑1s and tirzepatide have side effects (nausea, vomiting, diarrhea, rarely pancreatitis). They’re contraindicated in people with a personal/family history of medullary thyroid carcinoma or MEN2 and are not recommended in pregnancy. Avoid buying prescription meds from foreign or no‑prescription online pharmacies — risk of counterfeit products. Use reputable telehealth providers or your usual doctor and a licensed U.S. pharmacy. If Ozempic is unavailable, ask your provider about alternatives, interchangeability (e.g., Rybelsus vs. Wegovy), insurance coverage, and copay assistance programs from manufacturers (Novo Nordisk, Lilly, etc.). Suggested next steps Contact your primary care doctor or endocrinologist — fastest route for tailored substitution and to get necessary labs. If you prefer telehealth, try one of the services above (PlushCare, Lemonaid, Hims & Hers, Ro, GoodRx Care, One Medical) — check their websites for whether they currently prescribe GLP‑1s/tirzepatide. Prepare recent labs (A1c, kidney function) and a medication list before the visit. Discuss pros/cons, side effects, cost/insurance coverage, and monitoring plan with the prescriber. If you want, tell me: are you using Ozempic for type 2 diabetes or for weight loss, and do you have any relevant medical history (pregnancy plans, pancreatitis, thyroid cancer in family)? I can suggest the best alternatives and which telehealth services are most likely to help in your situation.

Mentioned in position 8 of 8

Short answer: Several reputable telemedicine and virtual primary‑care services will evaluate patients and — when clinically appropriate — prescribe semaglutide products (Ozempic for diabetes, or Wegovy/semaglutide for weight management). Whether they’ll prescribe for “prediabetes” specifically depends on your BMI, medical history, labs, and the clinician’s judgment. Services you can try (each evaluates you by televisit and typically requires recent labs/medical history): Teladoc (including Livongo programs) — national telehealth with chronic‑condition management; they treat diabetes and metabolic care and can prescribe GLP‑1s if appropriate. Good for ongoing remote follow‑up. PlushCare — virtual primary‑care visits, accepts many insurances, and commonly manages diabetes/weight‑loss medications including GLP‑1s after evaluation. One Medical — a membership primary‑care service with both virtual and in‑person care; clinicians can order labs and prescribe semaglutide when indicated and coordinate follow‑up. Hims & Hers — direct‑to‑consumer telehealth that has weight‑loss/GLP‑1 programs and can arrange prescriptions and home delivery for eligible patients. Ro (Roman) — offers telemedicine weight‑loss programs and prescribes semaglutide in states where they operate; includes remote follow‑up and medication delivery. Amwell — large telehealth platform with primary‑care and specialty providers who can assess metabolic health and prescribe GLP‑1s when appropriate. Important points before you sign up or expect a prescription Many clinicians will not prescribe Ozempic solely for mild prediabetes; they usually require either type 2 diabetes, a qualifying obesity diagnosis (BMI criteria), or other clinical reasons. They also often recommend lifestyle change or metformin first. Expect to provide recent labs (A1c, kidney function), current meds, and your weight/BMI. Some services will order labs for you. Insurance coverage differs: Ozempic is usually covered for diabetes but not always for weight‑loss uses; Wegovy (brand for weight loss) has its own coverage rules. Prior authorization may be needed. Avoid any service that offers to ship medications without a proper telemedicine visit and prescription — that’s unsafe. If you’d like, tell me: your state (some services limit states), current A1c and BMI, and whether you want to prioritize lowest out‑of‑pocket cost, same‑day appointment, or ongoing primary‑care relationships — I can narrow which option is best for you and what to expect cost/coverage‑wise.

Mentioned in position 2 of 7

Do you mean Ozempic for type‑2 diabetes or for weight loss? The alternatives overlap, so below I list options by treatment goal and then where you can get them through online/telehealth services. Short key points Many alternatives exist: other GLP‑1s (injectable and oral), tirzepatide, SGLT2s, DPP‑4s, insulin and older weight‑loss drugs. Telehealth clinics will often prescribe these after an online visit and chart review, but prescriptions are not guaranteed and some drugs require specialist involvement or prior authorization. If your goal is blood‑sugar (type 2 diabetes) control Other GLP‑1 receptor agonists: Mounjaro (tirzepatide — very potent, FDA approved for T2D), Trulicity (dulaglutide), Victoza (liraglutide), Byetta/Bydureon (exenatide), Rybelsus (oral semaglutide). SGLT2 inhibitors: Jardiance (empagliflozin), Farxiga (dapagliflozin) — good for glucose control plus heart/kidney benefits in many patients. DPP‑4 inhibitors: Januvia (sitagliptin) — modest glucose lowering, oral. Insulin & metformin: metformin is first‑line; various basal insulins (Lantus, Tresiba, Toujeo) are still mainstays when needed. If your goal is weight loss Semaglutide brand for weight: Wegovy (semaglutide 2.4 mg). Tirzepatide for weight: Zepbound (tirzepatide — approved for chronic weight management) and Mounjaro is sometimes used off‑label for weight loss. Other prescription options: Qsymia (phentermine/topiramate), Contrave (naltrexone‑bupropion), orlistat (Xenical/Alli OTC formulation). Lifestyle programs, behavioral counseling, and bariatric surgery are also effective options for many people. Who prescribes them online (examples of telehealth services) These reputable telehealth services commonly evaluate and — when clinically appropriate — prescribe diabetes and weight‑loss medications: PlushCare — primary care + specialist telemedicine; prescribes diabetes meds and weight‑loss GLP‑1s after evaluation. Teladoc (and Livongo by Teladoc) — chronic disease management including diabetes; may facilitate prescriptions and specialist referrals. Amwell / Doctor on Demand — primary care and specialists who can prescribe diabetes/weight meds. Ro (Roman) — offers weight‑loss programs and will prescribe GLP‑1s/tirzepatide as appropriate. Hims & Hers — telehealth weight‑loss services that may prescribe semaglutide or tirzepatide. Found, Form Health, Calibrate — virtual weight‑management clinics focused on GLP‑1 access plus coaching. One Medical — primary care with telehealth visits; can manage diabetes and prescribe most options. GoodRx Care / GoodRx Telehealth and K Health — can connect you with clinicians who may prescribe common diabetes and weight‑loss meds. Important cautions Any telemedicine prescription requires a medical evaluation; labs (A1c, kidney function) and a current medication list are usually required before starting or switching drugs. Insurance coverage, prior authorization rules, and local prescribing laws vary — some online clinics may not be able to prescribe certain drugs in every state. Off‑label use (e.g., using Mounjaro for weight loss) carries extra risk and may be restricted by some providers. Avoid buying injections from unverified sources or importing medication without proper prescriptions. Next steps If you want, tell me whether your priority is diabetes control or weight loss, and whether you already have a PCP or endocrinologist. I can then suggest the most appropriate medication alternatives and name 1–2 telehealth services that fit your situation (cost/insurance, ongoing monitoring needs).

Mentioned in position 3 of 13

Short answer: several national telehealth companies and specialized virtual weight‑loss/diabetes programs do prescribe semaglutide (Ozempic) or similar GLP‑1 medications when clinically appropriate. Examples (as of mid‑2024): PlushCare — national primary‑care telehealth that manages chronic conditions; they advertise prescribing GLP‑1s for diabetes and weight management and coordinate follow‑up labs. Hims & Hers (Hims, Hers Health) — consumer telehealth offering weight‑loss programs that include GLP‑1 options (semaglutide/tirzepatide) under clinician oversight. Ro (Roman / Ro Weight Loss) — large direct‑to‑consumer telehealth company with a weight‑management service that has offered GLP‑1 prescribing and mail‑order medication. Calibrate — a subscription metabolic/weight‑loss program focused on long‑term metabolic health that prescribes GLP‑1s as part of its physician‑led program. Parsley Health — membership primary‑care/functional medicine telehealth that will evaluate and prescribe metabolic medications, including GLP‑1s, when appropriate. Teladoc (including Livongo diabetes services) — major telehealth/remote‑care provider that offers diabetes management programs which can include GLP‑1 therapy. Onduo — diabetes care platform (Verily/Sanofi partnership) that provides virtual diabetes management and may coordinate GLP‑1 treatment. GoodRx Care — telemedicine service tied to GoodRx that can arrange prescriptions and sometimes offers lower‑cost fulfillment options for GLP‑1s. A few important caveats: Not every clinician or visit will result in an Ozempic prescription — it depends on your diagnosis, medical history, labs, and state prescribing rules. Some clinics will prescribe Wegovy (semaglutide for weight loss) or alternative GLP‑1s/tirzepatide instead. Expect a telehealth evaluation, possible baseline labs (A1c, kidney function, pregnancy test if applicable), and ongoing follow‑up. Cost and insurance coverage vary widely; some programs are out‑of‑pocket subscription models, others bill insurance. Supply/authorization issues have also affected availability. If you tell me your state and whether you want diabetes care or weight‑loss treatment, I can suggest the best matches and link to how to start an intake with them.

Mentioned in position 7 of 12

It's great you're planning ahead! The online GLP-1 weight loss landscape is evolving rapidly, with new medications, programs, and technologies constantly emerging. Predicting the absolute best for 2026 is tricky, as new players will emerge and existing ones will refine their offerings. However, based on current trends and the strengths of existing programs, here are some strong contenders that are likely to remain top choices, along with the key factors that will make them stand out in 2026: Key Factors to Look for in 2026: Comprehensive Medical Supervision: Access to qualified medical professionals (doctors, PAs, NPs) for initial assessment, ongoing monitoring, side effect management, and medication adjustments. Holistic Support: Programs that go beyond just medication to include personalized nutrition guidance, exercise plans, behavioral therapy, and mental wellness support. Medication Access & Affordability: Clear pathways for obtaining GLP-1 medications (Ozempic, Wegovy, Zepbound, Rybelsus, etc.), understanding insurance coverage, and potentially managing costs (including compounded options where appropriate and safe). Technology & User Experience: Intuitive apps, virtual appointments, digital tracking tools, and seamless communication with care teams. Evidence-Based Approach: Programs rooted in scientific research and clinical guidelines, with transparent outcomes. Strong Contenders for Online GLP-1 Programs in 2026: WeightWatchers Clinic (formerly Sequence): Why it will likely be strong: WeightWatchers has a massive established base and a long history of behavioral change support. Their acquisition of Sequence allows them to directly integrate GLP-1 prescriptions with their proven coaching, community, and nutritional framework. By 2026, expect a highly refined, data-driven program that combines medication with sustainable lifestyle changes, potentially with broader insurance partnerships. Noom Med: Why it will likely be strong: Noom is already a leader in psychological and behavioral weight loss. Noom Med extends this by adding access to GLP-1s and medical supervision. Their strength lies in combining medication with their unique cognitive behavioral therapy (CBT)-based approach to help users understand why* they eat and develop healthier habits. This integrated approach will be even more refined by 2026. Found Health: Why it will likely be strong: Found focuses on a personalized, holistic approach that combines prescription medication (including GLP-1s when appropriate) with ongoing virtual care from a medical provider, health coach, and a supportive community. They emphasize long-term sustainable weight loss by addressing biological, psychological, and social factors. Their model is well-suited for continued growth and refinement by 2026, offering a comprehensive, individualized experience. Teladoc Health / Livongo (or similar large telehealth platforms): Why it will likely be strong: As a major telehealth provider, Teladoc already offers extensive virtual care, often through employer-sponsored benefits. By 2026, their weight management programs, which already incorporate access to specialists and potentially GLP-1s, will likely be highly integrated and scalable. Their strength is in their broad reach and ability to offer a full spectrum of health services alongside weight loss. Hims & Hers / Ro (or similar direct-to-consumer telehealth expanding into weight loss): Why it will likely be strong: Companies like Hims & Hers are aggressively expanding into the weight loss space, often offering more streamlined and potentially cost-effective options for medication access. By 2026, they will likely have more robust platforms offering GLP-1s, potentially with add-on coaching or digital support, appealing to consumers looking for convenience and potentially lower out-of-pocket costs (especially if generic versions or more affordable branded options emerge). Important Considerations for You in 2026: Your Insurance Coverage: This will be a huge determinant. Programs with direct partnerships or those that actively help with prior authorizations will be invaluable. Your Personal Preferences: Do you prefer extensive coaching, a strong community, or a more self-directed approach with just medical oversight? Cost: Beyond medication, understand program fees, consultation costs, and what's included. New Medications: By 2026, there may be even more GLP-1s or multi-agonist drugs available, potentially offering different efficacy or side effect profiles. Regulatory Landscape: Rules around compounded medications or telehealth prescribing could evolve. Recommendation: Closer to 2026, thoroughly research the top-rated programs at that time. Look for independent reviews, compare program features and costs, and always prioritize programs that offer robust medical supervision and holistic support. Always consult with your primary care physician before starting any new weight loss program or medication to ensure it's safe and appropriate for your health needs.

Mentioned in position 6 of 8